Voluntary Health Organizations Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032
The Business Research Company’s Voluntary Health Organizations Global Market Report...
The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the 110 years since it was founded. But the booming...
Novo Nordisk is deepening its investment in cardiometabolic disease drug development, this time with a partnership with German biotech Evotec.
The companies announced Tuesday a new...
RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 22, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg tablets to...
Pictured: People in suits with their thumbs down/iStock, iammotos The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee on Thursday unanimously voted against Intarcia Therapeutics’...
Dive Brief:
The Novo Nordisk Foundation, the controlling owner of the Danish drugmaker, will spend up to 950 million kroner, or roughly $136 million, to...
September is Polycystic Ovary Syndrome (PCOS) Awareness Month, dedicated to spreading knowledge on this common yet often misunderstood health condition. PCOS affects millions of...